Enhancement of Th2 response in IL-6-deficient mice immunized with myelin oligodendrocyte glycoprotein

Journal of Neuroimmunology

Volumn 105, Issue 2, 2000, Pages 120-123

  Okuda, Yoshinobu ^a   Sakoda, Saburo ^b   Saeki, Yukihiko ^b   Kishimoto, Tadamitsu ^c   Yanagihara, Takehiko ^b  

^a LA TROBE UNIVERSITY   (Australia)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Cytokines; Experimental autoimmune encephalomyelitis; IL 6; Myelin oligodendrocyte glycoprotein

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; MYELIN ASSOCIATED GLYCOPROTEIN; RECOMBINANT INTERLEUKIN 6;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE RESISTANCE; FEMALE; IMMUNE DEFICIENCY; IMMUNIZATION; LYMPH NODE CELL; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MYELIN-ASSOCIATED GLYCOPROTEIN; RNA, MESSENGER; TH2 CELLS;

EID: 0034717832     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00192-2     Document Type: Article

References (28)

1. Cua D.J., Hinton D.R., Stohlman S.A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J. Immunol. 155:1995;4052-4059.
2. Eugster H.-P., Frei K., Kopf M., Lassmann H., Fontana A. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:1998;2178-2187.
3. Falcone M., Bloom B.R. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185:1997;901-907.
4. Ferber I.A., Brocke S., Edwards C.T., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C.G. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:1996;5-7.
5. Frei K., Eugster H.-P., Bopst M., Constantinescu C.S., Lavi E., Fontana A. Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1997;2177-2182.
6. Gazzinelli R.T., Hieny S., Wynn T.A., Wolf S., Sher A. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA. 90:1993;6115-6119.
7. Gijbels K., Brocke S., Abrams J.S., Steinman L. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol. Med. 1:1995;795-805.
8. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspect of interleukin 6. Immunol. Today. 11:1990;443-449.
9. Kishimoto T. The biology of interleukin-6. Blood. 74:1989;1-10.
10. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Köhler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 368:1994;339-342.
11. Körner H., Riminton D.S., Strickland D.H., Lemckert F.A., Pollard J.D., Sedgwick J.D. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1997;1585-1590.
12. Liu J., Marino M.W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A.J., Old L., Bernard C.C.A. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4:1998;78-83.
13. Mendel I., Katz A., Kozack N., Ben-Nun A., Revel M. Interleukin-6 function in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol. 28:1998;1727-1737.
14. Ohshima S., Saeki Y., Mima T., Sasai M., Nishioka K., Nomura S., Kopf M., Katada Y., Tanaka T., Suemura M., Kishimoto T. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc. Natl. Acad. Sci. USA. 95:1998;8222-8226.
15. Okuda Y., Nakatsuji Y., Fujimura H., Esumi H., Ogura T., Yanagihara T., Sakoda S. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62:1995;103-112.
16. Okuda Y., Sakoda S., Bernard C.C.A., Yanagihara T. The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an up-regulation of both proinflammatory and immunoregulatory cytokines in the central nervous system. J. Interferon. Cytokine. Res. 18:1998;415-421.
17. Okuda Y., Sakoda S., Yanagihara T. The pattern of cytokine gene expression in lymphoid organs and peripheral blood mononuclear cells of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 87:1998;147-155.
18. Okuda Y., Sakoda S., Bernard C.C.A., Fujimura H., Saeki Y., Kishimoto T., Yanagihara T. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10:1998;703-708.
19. Okuda Y., Sakoda S., Fujimura H., Saeki Y., Kishimoto T., Yanagihara T. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glycoprotein 35-55 induced experimental autoimmune encephalomyelitis. J. Neuroimmunol. 101:1999;188-196.
20. Olsson T. Critical influence of cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:1995;245-268.
21. Riminton D.S., Körner H., Strickland D.H., Lemckert F.A., Pollard J.D., Sedgwick J.D. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J. Exp. Med. 187:1998;1517-1528.
22. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183:1996;1345-1355.
23. Samoilova E.B., Horton J.L., Hilliard B., Liu T.T., Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:1998;6480-6486.
24. Segal B.M., Dwyer B.K., Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187:1998;537-546.
25. Suen W.E., Bergman C.M., Hjelmström P., Ruddle N.H. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 186:1997;1233-1240.
26. Van der Veen R.C., Stohlman S.A. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48:1993;213-220.
27. Willenborg D.O., Fordham S., Bernard C.C.A., Cowden W.B., Ramshaw I.A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:1996;3223-3227.
28. Yasukawa K., Saito T. A new system for the expression of human interleukin-6 in Escherichia coli. Biotech. Lett. 12:1990;419-424.